# Delivery Order #15B50927F00000001

Delivery Order for Helsinn Therapeutics' VALCHLOR Gel under VA Federal Supply Schedule

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $11,969.18
**Ceiling:** $11,969.18

**Awarded:** October 01, 2026
**Period of Performance:** Oct 01, 2026 - Oct 31, 2026

**Identifier:** 15B50927F00000001
**NAICS:** 325412

This award is a delivery order contract issued to Helsinn Therapeutics (U.S.), Inc., a pharmaceutical company specializing in cancer treatments. The contract involves the procurement of VALCHLOR Gel, a specialized cancer medication, to support the Department of Veterans Affairs' healthcare services. This delivery order is part of a larger, ongoing Federal Supply Schedule contract that enables a steady and reliable supply of critical cancer therapies to veterans. The scope includes supplying specified quantities of VALCHLOR Gel within a set one-month performance period, ensuring timely availability of treatment options. The award was competitively procured under the overarching Federal Supply Schedule vehicle, which facilitates efficient acquisitions for veteran healthcare. The contract contributes significantly to enhancing veteran care by maintaining access to innovative pharmaceuticals. The award and performance dates align with the ongoing multi-year schedule agreement spanning from early 2025 to early 2030, reflecting continued agency commitment to veteran health support.

### Description

FY27 PHARMACY HELSINN-VALCHLOR GEL

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B50927F00000001_1540_36F79725D0061_3600)
